Immunology and Microbiology
Acinetobacter
6%
Acinetobacter Baumannii
9%
Aedes aegypti
5%
Allele
6%
Anopheles
9%
Anopheles Gambiae
21%
Antibiotic Sensitivity
16%
Antibody Screening
8%
Antimicrobial Agent
8%
Antimicrobial Resistance
76%
Antimicrobial Resistance
11%
Aspergillus
8%
Bacilli
5%
Bacterial Load
5%
Blood Flow
6%
Candida
8%
CD4
6%
Cephalosporin Resistance
6%
Cladistics
13%
Coagulase Negative Staphylococcus
12%
Coinfection
11%
Colony Forming Unit S
5%
Complement Receptor 1
5%
Disk Diffusion
7%
Drug Resistance
13%
Dynamics
11%
Enterobacterales
14%
Enterobacteriaceae
13%
Erythrocyte
6%
Escherichia coli
55%
Extract
7%
Gastroenteritis
6%
Genetic Variability
16%
Gram-Negative Bacteria
21%
Haplotype
7%
Hemodialysis
5%
Hepatitis B Virus
20%
Hepatitis C Virus
5%
Human Immunodeficiency Virus
61%
Human Immunodeficiency Virus 1
18%
Human Immunodeficiency Virus Infection
6%
Immunity
5%
Infectious Agent
43%
Insecticide Resistance
24%
Klebsiella pneumoniae
22%
Lineages
15%
Malaria Control
10%
Matrix-Assisted Laser Desorption-Ionization
5%
Medline
11%
Methicillin-Resistant Staphylococcus Aureus
24%
Microorganism
8%
Minimum Inhibitory Concentration
11%
Mortality Rate
5%
Multidrug Resistance
21%
Multilocus Sequence Typing
10%
Nasopharynx
6%
Next Generation Sequencing
5%
Parasitology
11%
Penicillin
16%
Peptoclostridium difficile
6%
Phylogeny
11%
Plasmodium
21%
Plasmodium falciparum
39%
Pneumococcal Vaccine
23%
Pneumococcus
38%
Polymerase Chain Reaction
7%
Population Structure
13%
Praziquantel
5%
Prevalence
100%
Pseudomonas aeruginosa
15%
Rotavirus
24%
Rotavirus Vaccine
6%
Salmonella
14%
Schistosoma haematobium
8%
Schistosomiasis
6%
Scopus
8%
Serotype
63%
Sickle Cell
23%
Single Nucleotide Polymorphism
13%
Species Identification
6%
Sporozoite
6%
Staphylococcus Aureus
40%
Streptococcus
6%
Streptococcus Pneumonia
24%
Superoxide
5%
Urinary Tract
5%
Urine Sampling
10%
Vibrio Cholerae O1
7%
Viral Load
12%
Web of Science
8%
Whole Genome Sequencing
11%
Medicine and Dentistry
Allele
5%
Anopheles
5%
Anopheles Gambiae
9%
Antibiogram
5%
Antibiotic Resistance
45%
Antibiotics
16%
Antibody Screening
5%
Antiinfective Agent
17%
Antiretroviral Therapy
12%
Apoplexy
17%
Bite
7%
Bloodstream Infection
19%
Case Management
5%
Cephalosporin Resistance
9%
Chronic Pulmonary Aspergillosis
5%
Cohort Effect
7%
Cost-Effectiveness Analysis
6%
COVID-19
15%
Cross Sectional Study
15%
Diagnosis
9%
Diagnostic Accuracy
11%
Diarrhea
5%
Disease
35%
Drug Resistance
8%
Enterobacteriaceae
8%
Escherichia coli
10%
Extended Spectrum Beta Lactamase
9%
Fomite
5%
Gastroenteritis
9%
Gram-Negative Bacteria
5%
Health Care Cost
10%
Helminth
7%
Hepatitis B Virus
7%
Hospital Infection
7%
Household
7%
Human Immunodeficiency Virus
52%
Human Immunodeficiency Virus Infection
5%
Infection
40%
Infection Control
5%
Insecticide Resistance
14%
Klebsiella pneumoniae
9%
Lipoarabinomannan
11%
Low and Middle Income Countries
6%
Medical Research
5%
Meningitis
7%
Meta-Analysis
8%
Methicillin Resistant Staphylococcus Aureus
7%
Multidrug Resistance
9%
Odds Ratio
5%
Outpatient
10%
Pathogen
26%
Pediatrics
13%
Penicillin Derivative
7%
Pneumococcus
20%
Pneumococcus Vaccine
14%
Prevalence
49%
Primary Health Care
6%
Public Health
19%
Quality of Life
6%
Resistance Mutation
9%
Retrospective Study
8%
Rotavirus
10%
Salmonella
7%
Schistosoma haematobium
6%
Schistosomiasis
8%
Serotype
32%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Sickle-Cell Disease
18%
Staphylococcus Aureus
12%
Streptococcus Pneumonia
13%
Study Participant
9%
Systematic Review
18%
Tertiary Care
9%
Third Generation Cephalosporin
9%
Urine Sampling
11%
Vector Control
10%
Voltage Gated Sodium Channel
5%
Whole Genome Sequencing
6%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
8%
Ampicillin
7%
Anemia
6%
Antibiotic Resistance
44%
Antibiotics
40%
Antifungal Agent
5%
Antiinfective Agent
32%
Antimicrobial Agent
9%
Antimicrobial Resistance
20%
Bacteriophage
8%
Bloodstream Infection
13%
Candida
6%
Carbapenem
7%
Carbapenem Resistance
5%
Carbapenemase
11%
Catheter Infection
5%
Cefotaxime
5%
Ceftriaxone
5%
Cefuroxime
5%
Cerebrovascular Accident
5%
Ciprofloxacin
7%
Coagulase Negative Staphylococcus
9%
Combination Therapy
5%
Cotrimoxazole
9%
Cross-Sectional Study
24%
CYP2B6
5%
Diarrhea
8%
Disease
30%
Drug Resistance
16%
Efavirenz
5%
Elimination
7%
Enterobacteriaceae
8%
Escherichia coli
17%
Extended Spectrum Beta Lactamase
12%
Fomite
5%
Gastroenteritis
10%
Gentamicin
6%
Gram Negative Bacterium
14%
Helminth
8%
Hemodialysis
5%
Hepatitis B Virus
13%
HIV
52%
Hospital Infection
11%
Infection
55%
Infectious Agent
30%
Klebsiella pneumoniae
9%
Lipoarabinomannan
8%
Meningitis
7%
Meropenem
5%
Methicillin-Resistant Staphylococcus Aureus
7%
Microorganism
5%
Minimum Inhibitory Concentration
6%
Mixed Infection
8%
Multidrug Resistance
16%
Pandemic
5%
Penicillin Derivative
9%
Plasmodium falciparum
16%
Pneumococcus Vaccine
8%
Prevalence
69%
Pseudomonas aeruginosa
8%
Respiratory Tract Infection
7%
Rotavirus
14%
Salmonella
13%
SARS Coronavirus
9%
Schistosomiasis
6%
Sickle Cell Anemia
15%
Staphylococcus Aureus
19%
Streptococcus
12%
Tetracycline
6%